Back
Neurocrine Biosciences, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
68
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$148.69
Seasonality Move:
9.22%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiNeurocrine Biosciences, Inc. Stock Forecast
-
Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 28.7% based on the past 29 years of stock performance.
-
Neurocrine Biosciences, Inc. has risen higher in 17 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.62%
-
Is Neurocrine Biosciences, Inc. Stock Undervalued?The current Neurocrine Biosciences, Inc. [NBIX] share price is $154.06. The Score for NBIX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Neurocrine Biosciences, Inc. has on average historically risen by 28.7% based on the past 29 years of stock performance.
Neurocrine Biosciences, Inc. Stock Rating
Buy
68
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. overpriced?
-
Neurocrine Biosciences, Inc. has risen higher in 17 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.62%
Neurocrine Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
160.18
52-Week Low:
84.23
Prediction Charts
Market Cap:
15.4B
Price in USD:
154.06
Volume:
768.2K
Beta:
0.78
Technical Analysis
SMA50:
145.41
SMA100:
141.12
SMA200:
129.07
52-Wk Change:
21.59%
Stock Predictions
-
Is Neurocrine Biosciences, Inc. stock public?Yes, Neurocrine Biosciences, Inc. is a publicly traded company.
-
What is the Neurocrine Biosciences, Inc. stock quote today?The Neurocrine Biosciences, Inc. stock price is 154.06 USD today.
-
How to buy Neurocrine Biosciences, Inc. stock online?You can buy Neurocrine Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-25 | 141.67 | 143.53 | 144.75 | 140.67 |
| Nov-26 | 146.75 | 151.58 | 153.54 | 146.00 |
| Nov-28 | 152.78 | 152.16 | 153.70 | 150.41 |
| Dec-1 | 152.38 | 150.88 | 153.29 | 149.58 |
| Dec-2 | 151.13 | 152.48 | 153.79 | 150.84 |
| Dec-3 | 153.20 | 151.96 | 154.35 | 150.26 |
| Dec-4 | 152.00 | 154.22 | 154.31 | 151.01 |
| Dec-5 | 154.47 | 155.51 | 156.76 | 153.38 |
| Dec-8 | 156.65 | 154.99 | 160.18 | 154.74 |
| Dec-9 | 153.45 | 155.02 | 156.27 | 152.29 |
| Dec-10 | 155.87 | 155.63 | 156.70 | 151.59 |
| Dec-11 | 153.39 | 154.75 | 156.46 | 153.30 |
| Dec-12 | 155.00 | 152.80 | 155.29 | 151.09 |
| Dec-15 | 152.78 | 154.06 | 155.55 | 151.12 |
Neurocrine Biosciences, Inc. Earnings
Neurocrine Biosciences, Inc. Earnings Report: Per Share Neurocrine Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences, Inc. Forecast Revenue Growth
Neurocrine Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $2.24 per share.
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.